Vertex Pharmaceuticals
VRTX
$455.34
Share price
2.77%
Change (1 day)
40.70%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Total debt
Total debt on the balance sheet as of March 2024 : $0.72 B
According to Vertex Pharmaceuticals's latest financial reports the company's total debt is $0.72 B. A company’s total debt is the sum of all current and non-current debts.
Vertex Pharmaceuticals - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.80 B | -10.15% |
| 2022-12-31 | $0.89 B | -7% |
| 2021-12-31 | $0.96 B | 3.81% |
| 2020-12-31 | $0.93 B | 40.84% |
| 2019-12-31 | $0.66 B | 12.75% |
| 2018-12-31 | $0.58 B | -3.23% |
| 2017-12-31 | $0.60 B | -27.87% |
| 2016-12-31 | $0.84 B | 1.76% |
| 2015-12-31 | $0.82 B | 0.16% |
| 2014-12-31 | $0.82 B | 62.85% |
| 2013-12-31 | $0.50 B | -27.31% |
| 2012-12-31 | $0.69 B | 52.85% |
| 2011-12-31 | $0.45 B | -15.09% |
| 2010-12-31 | $0.53 B | 249.07% |
| 2009-12-31 | $0.15 B | -46.49% |
| 2008-12-31 | $0.28 B | 1337.72% |
| 2007-12-31 | $19.99 M | -83.84% |
| 2006-12-31 | $0.12 B | -31.28% |
| 2005-12-31 | $0.18 B | -46.24% |
| 2004-12-31 | $0.33 B | 0.46% |
| 2003-12-31 | $0.33 B | 1.62% |
| 2002-12-31 | $0.32 B | 0.16% |
| 2001-12-31 | $0.32 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 4,562.69% | 🇺🇸 USA |
 AbbVie ABBV | $74.00 B | 10,159.39% | 🇺🇸 USA |
 Gilead Sciences GILD | $25.19 B | 3,392.86% | 🇺🇸 USA |
 Merck MRK | $34.21 B | 4,644.07% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 7,859.10% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $46.99 M | -93.48% | 🇺🇸 USA |